Most patients with persistent pulmonary symptoms after recovering from mild to moderate COVID-19 infection have normal ...

Arcturus stock drops on interim Phase 2 results for ARCT-032, showing promising mucus reduction in cystic fibrosis patients but no initial FEV₁ improvement.

High levels of phenotypic age acceleration (PhenoAgeAccel) were found to have a more significant effect on lung function in patients with chronic obstructive pulmonary disease (COPD), older patients, ...

The development could help scientists develop patient-specific treatments and one day offer a lab-grown lung transplant ...

Lung diseases like tuberculosis and cystic fibrosis can be difficult to treat. In part, that's because the two-dimensional models researchers use to study the diseases don't accurately reflect the ...

If there is one medical exam that everyone in the world has taken, it's a chest x-ray. Clinicians can use radiographs to tell if someone has tuberculosis, lung cancer, or other diseases, but they ...

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...

Race-neutral pulmonary function testing, now recommended by ATS and implemented at Boston Medical Center, has had a long road ...

An artificial intelligence (AI) model that can estimate with high accuracy a person's lung function just by using a chest radiograph has been successfully developed. If there is one medical exam that ...

Trials of Duchenne muscular dystrophy (DMD) treatments targeting declining lung or upper limb function, which are typically limited to nonambulatory patients, could also include ambulatory patients, ...